GI Monitor, (IBD) Crohn's and Colitis Symptom Tracking Application From WellApps LLC, Expands to Android and Adds Real-time Sync Across iPhone, iPad, Android and BlackBerry
Poster: SySAdmin
Posted on September 27, 2010 at 5:21:01 AM
GI Monitor, (IBD) Crohn's and Colitis Symptom Tracking Application From WellApps LLC, Expands to Android and Adds Real-time Sync Across iPhone, iPad, Android and BlackBerry
Developed by an Ulcerative Colitis patient with help from GI specialists, GI Monitor, the leading symptom tracking application for (IBD) Crohn's and Ulcerative Colitis, is now available on Android smartphones as well as iPhone, iPad and BlackBerry.
UPPER SADDLE RIVER, N.J., Sept. 27 /PRNewswire/ -- WellApps, LLC announced today that it has expanded GI Monitor, its successful (IBD) Crohn's and Colitis symptom tracking application, to Android phones in response to patient demand. GI Monitor is a free symptom tracking service that allows patients to log IBD symptoms such as bowel movements, pain and stress and make correlations with medications and diet. Detailed reports and charts can be printed or emailed to physicians, resulting in optimal treatment. The service, which is free to patients, is now available for iPhone, iPad, iTouch, Android and BlackBerry and supports real-time sync across all platforms.
Inspired by an ongoing battle with Ulcerative Colitis, 35-year old Brett Shamosh, a digital media executive from Bergen County, NJ, decided to use the booming smartphone app market to help fellow IBD patients. Since then, he has started his own company developing and distributing symptom tracking applications for patients with chronic illnesses. Shamosh says, "The penetration of smartphones into the consumer market has opened up some startling possibilities for the healthcare space." He adds, "WellApps enhances communication between patients, physicians and researchers to limit periods of disease activity, increase compliance with treatment regimens and significantly reduce healthcare spending."
WellApps also provides unique opportunities to Pharmaceutical marketers. Bill Jennings, CEO of Good Health Media, the fastest growing Health Ad Network reaching 38 million monthly unique visitors (Comscore), says "Working with WellApps and a great product like GI Monitor allows us to extend valuable programs to our pharma clients and engage patients in powerful ways." Dan Reinhardt, President of Evidence Based Marketing firm Return on Focus, adds "GI Monitor offers patients and physicians access to an unprecedented level of real-world evidence about Crohn's and Ulcerative Colitis. Pharmaceutical marketers have a unique opportunity to help patients improve overall outcomes."
GI Monitor is free to patients and is currently available at http://www.wellapps.com
About WellApps, LLC - WellApps develops and distributes symptom tracking applications for patients with chronic illnesses. The data collected is compiled into easy-to-read reports for physicians, resulting in optimal patient treatment and reduced periods of active disease. Patients can also access interactive charts to see correlations between symptoms and understand how compliance to medication affects their well being.
De-identified data from our patient population is collected anonymously and shared with researchers to make progress in the treatment of chronic illnesses.
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
SOURCE WellApps, LLC
WellApps, LLC
CONTACT: Brett Shamosh of WellApps, LLC, +1-201-446-7224, brett@wellapps.com
Web Site: http://www.wellapps.com/
Developed by an Ulcerative Colitis patient with help from GI specialists, GI Monitor, the leading symptom tracking application for (IBD) Crohn's and Ulcerative Colitis, is now available on Android smartphones as well as iPhone, iPad and BlackBerry.
UPPER SADDLE RIVER, N.J., Sept. 27 /PRNewswire/ -- WellApps, LLC announced today that it has expanded GI Monitor, its successful (IBD) Crohn's and Colitis symptom tracking application, to Android phones in response to patient demand. GI Monitor is a free symptom tracking service that allows patients to log IBD symptoms such as bowel movements, pain and stress and make correlations with medications and diet. Detailed reports and charts can be printed or emailed to physicians, resulting in optimal treatment. The service, which is free to patients, is now available for iPhone, iPad, iTouch, Android and BlackBerry and supports real-time sync across all platforms.
Inspired by an ongoing battle with Ulcerative Colitis, 35-year old Brett Shamosh, a digital media executive from Bergen County, NJ, decided to use the booming smartphone app market to help fellow IBD patients. Since then, he has started his own company developing and distributing symptom tracking applications for patients with chronic illnesses. Shamosh says, "The penetration of smartphones into the consumer market has opened up some startling possibilities for the healthcare space." He adds, "WellApps enhances communication between patients, physicians and researchers to limit periods of disease activity, increase compliance with treatment regimens and significantly reduce healthcare spending."
WellApps also provides unique opportunities to Pharmaceutical marketers. Bill Jennings, CEO of Good Health Media, the fastest growing Health Ad Network reaching 38 million monthly unique visitors (Comscore), says "Working with WellApps and a great product like GI Monitor allows us to extend valuable programs to our pharma clients and engage patients in powerful ways." Dan Reinhardt, President of Evidence Based Marketing firm Return on Focus, adds "GI Monitor offers patients and physicians access to an unprecedented level of real-world evidence about Crohn's and Ulcerative Colitis. Pharmaceutical marketers have a unique opportunity to help patients improve overall outcomes."
GI Monitor is free to patients and is currently available at http://www.wellapps.com
About WellApps, LLC - WellApps develops and distributes symptom tracking applications for patients with chronic illnesses. The data collected is compiled into easy-to-read reports for physicians, resulting in optimal patient treatment and reduced periods of active disease. Patients can also access interactive charts to see correlations between symptoms and understand how compliance to medication affects their well being.
De-identified data from our patient population is collected anonymously and shared with researchers to make progress in the treatment of chronic illnesses.
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
SOURCE WellApps, LLC
WellApps, LLC
CONTACT: Brett Shamosh of WellApps, LLC, +1-201-446-7224, brett@wellapps.com
Web Site: http://www.wellapps.com/